PATENT CLAIM ANALYSIS

Application Number: 16264182
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "133100"]

Abstract:
This document provides methods and materials related to treating renal cell carcinoma. For example, methods and materials for assessing a cancer patient (e.g., a renal cell carcinoma patient) for tumor or peritumoral tissue containing CD14 +  cells and proceeding with a cancer treatment option (e.g., a renal cell carcinoma treatment option) based on the presence, absence, or level of CD14 +  cells present within the tumor or peritumoral tissue are provided.

Claim (Index 1):
A method for treating a human having a solid tumor, wherein said method comprises:\n (a) determining whether or not tumor or peritumoral tissue from said human contains greater than 30 percent of CD14 +  cells, and (b) proceeding with a conventional ovarian cancer therapy if said tissue does not contain greater than 10 percent of CD14 cells, and proceeding with a therapy more aggressive than said conventional ovarian cancer therapy if said tissue contains greater than 10 percent of CD14 +  cells.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.74468
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13509089', '15643155', '14994980', '14889086', '11245713']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7440508552755433
- 35 USC 102 Novelty (BERT): 0.5634546878523006
- Combined Prediction Score: 0.725991238533219
- Mean Citation Score: 362.043232
- Max Citation Score: 442.1073
- Similarity Product: 385.48717287341947

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test